Dynamin Function by Tyrosine Phoshorylation
酪氨酸磷酸化的动力功能
基本信息
- 批准号:7194650
- 负责人:
- 金额:$ 14.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:PC12 cellsbeta adrenergic receptorbiological signal transductioncell linedynaminenzyme induction /repressionenzyme inhibitorsgenetic regulationimmunocytochemistryintermolecular interactionmolecular sitephosphorylationprotein localizationprotein purificationprotein sequenceprotein structure functionprotein tyrosine kinasereceptor expressionreceptor mediated endocytosisrecombinant proteinssite directed mutagenesisstimulant /agonisttyrosine
项目摘要
DESCRIPTION (provided by applicant): Vital cellular responses including cell
metabolism, proliferation and differentiation are all regulated by specific
interactions between extracellular ligands and their plasma membrane-anchored
receptors. Accessibility of ligand to receptor, is therefore, an important
facet in biological regulation. Receptor expression on the cell surface is
dictated, at least in part, by vesicle trafficking via the regulation of
receptor internalization. Internalization (also termed endocytosis) is an
important regulatory mechanism, which is implicated in receptor
resensitization, downregulation, and more recently in signal transduction.
Endocytosis of G protein-coupled receptors (GPCRs) and receptor tyrosine
kinases (RTKs) is dependent on the invagination and fission of clathrin coated
vesicles from the plasma membrane into the cytosol. Constriction of the pits
and fission of vesicles from the plasma membrane requires the GTPase activity
of dynamin. Recent evidence suggests that protein tyrosine phosphorylation is
also required for agonist-regulated internalization of cell surface receptors,
although the locus of this protein tyrosine phosphorylation remains undefined.
Dynamin has recently been shown to directly interact with the non-receptor
tyrosine kinase c-Src and to be a tyrosine phospho-protein. Therefore, we
hypothesize that tyrosine kinase activity may regulate endocytosis of receptors
by acting on molecules important for receptor internalization especially
dynamin. The present proposal introduces a novel regulatory mechanism for
dynamin's role in the process of receptor-mediated endocytosis. The central
hypothesis is that agonist-regulated tyrosine phosphorylation of dynamin
controls its function in receptor internalization and signaling. Experiments
will focus on identifying the molecular determinants involved in
receptor-regulated tyrosine phosphorylation of dynamin and elucidating the role
of tyrosine phosporylation of dynamin on its enzymatic activity. The specific
aims are: (1) To demonstrate the beta2 adrenergic receptor-regulated tyrosine
phosphorylation of endogenous dynamin I and to identify phosphorylated
residues; (2) To determine the in vivo mechanism(s) by which beta2 adrenergic
receptors regulate tyrosine phosphorylation of dynamin; and (3) To express and
purify recombinant dynamin proteins for use in vitro assays aimed at
determining the physiologic role for tyrosine phosphorylation of dynamin on its
enzymatic activity and receptor-mediated endocytosis.
描述(由申请人提供):重要的细胞反应,包括细胞
新陈代谢、增殖和分化都受到特定的调控
细胞外配体与其质膜锚定之间的相互作用
受体。因此,配体与受体的可及性是一个重要的因素
生物调节方面。细胞表面的受体表达为
至少部分地由通过调节的囊泡运输决定
受体内化。内化(也称为内吞作用)是一种
重要的调控机制,与受体有关
重新敏化、下调以及最近的信号转导。
G 蛋白偶联受体 (GPCR) 和受体酪氨酸的内吞作用
激酶(RTK)依赖于网格蛋白包被的内陷和裂变
囊泡从质膜进入细胞质。坑的收缩
囊泡从质膜分裂需要 GTP 酶活性
动力。最近的证据表明蛋白质酪氨酸磷酸化是
也是激动剂调节的细胞表面受体内化所必需的,
尽管该蛋白酪氨酸磷酸化的位点仍未确定。
Dynamin 最近被证明可以直接与非受体相互作用
酪氨酸激酶 c-Src 是一种酪氨酸磷酸蛋白。因此,我们
假设酪氨酸激酶活性可能调节受体的内吞作用
通过作用于对受体内化重要的分子,尤其是
动力。本提案引入了一种新的监管机制
动力在受体介导的内吞作用过程中的作用。中央
假设是激动剂调节的动力酪氨酸磷酸化
控制其在受体内化和信号传导中的功能。实验
将重点关注确定参与的分子决定因素
受体调节的动力酪氨酸磷酸化并阐明其作用
动力蛋白酪氨酸磷酸化对其酶活性的影响。具体的
目的是:(1)证明β2肾上腺素受体调节的酪氨酸
内源性动力蛋白 I 的磷酸化并鉴定磷酸化
残留物; (2) 确定β2肾上腺素能的体内机制
受体调节动力的酪氨酸磷酸化; (3) 表达和
纯化重组动力蛋白用于体外测定
确定动力酪氨酸磷酸化对其的生理作用
酶活性和受体介导的内吞作用。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yehia Daaka其他文献
Yehia Daaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yehia Daaka', 18)}}的其他基金
Prostaglandin Receptor Regulation of Kidney Cancer
前列腺素受体对肾癌的调节
- 批准号:
8239456 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
Prostaglandin Receptor Regulation of Kidney Cancer
前列腺素受体对肾癌的调节
- 批准号:
8066388 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
Prostaglandin Receptor Regulation of Kidney Cancer
前列腺素受体对肾癌的调节
- 批准号:
7456215 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
Prostaglandin Receptor Regulation of Kidney Cancer
前列腺素受体对肾癌的调节
- 批准号:
8433453 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
相似海外基金
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Cardiac Beta-Adrenergic Receptor Density, Evaluated by Cardiac Positron Emission Tomography, in Heart Failure with Atrial Fibrillation
通过心脏正电子发射断层扫描评估心房颤动心力衰竭患者的心脏β-肾上腺素能受体密度
- 批准号:
22K07801 - 财政年份:2022
- 资助金额:
$ 14.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research for predictive indicators of therapeutic response of beta-adrenergic receptor blockers using myocardial tissue of patients with heart failure
利用心力衰竭患者心肌组织研究β-肾上腺素能受体阻滞剂治疗反应的预测指标
- 批准号:
21K16031 - 财政年份:2021
- 资助金额:
$ 14.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10288087 - 财政年份:2017
- 资助金额:
$ 14.44万 - 项目类别:
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10063903 - 财政年份:2017
- 资助金额:
$ 14.44万 - 项目类别:
Beta adrenergic receptor resensitization in asthma
哮喘中的β肾上腺素能受体再敏化
- 批准号:
9205534 - 财政年份:2016
- 资助金额:
$ 14.44万 - 项目类别:
Impact of cardiac beta-adrenergic receptor density evaluated by cardiac PET on chronotropic incompetence
心脏 PET 评估心脏 β-肾上腺素能受体密度对变时性功能不全的影响
- 批准号:
15K09966 - 财政年份:2015
- 资助金额:
$ 14.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the mechanism in the aldosterone regulation through the beta-adrenergic receptor
通过β-肾上腺素受体调节醛固酮的机制研究
- 批准号:
24580463 - 财政年份:2012
- 资助金额:
$ 14.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)